Organigram Holdings Inc. (TSE:OGI – Free Report) – Equities research analysts at Atb Cap Markets issued their Q1 2025 EPS estimates for Organigram in a note issued to investors on Wednesday, December 18th. Atb Cap Markets analyst F. Gomes expects that the company will post earnings of ($0.03) per share for the quarter. The consensus estimate for Organigram’s current full-year earnings is $0.16 per share. Atb Cap Markets also issued estimates for Organigram’s Q2 2025 earnings at ($0.04) EPS, Q3 2025 earnings at ($0.02) EPS and FY2025 earnings at ($0.10) EPS.
Several other brokerages have also weighed in on OGI. Canaccord Genuity Group cut their target price on Organigram from C$3.60 to C$3.15 and set a “speculative buy” rating on the stock in a research report on Monday, December 9th. ATB Capital dropped their price target on Organigram from C$5.25 to C$3.50 in a research note on Tuesday, December 17th.
Organigram Stock Performance
TSE:OGI opened at C$2.22 on Monday. Organigram has a fifty-two week low of C$1.61 and a fifty-two week high of C$3.95. The firm’s 50 day moving average is C$2.26 and its two-hundred day moving average is C$2.30. The company has a market cap of C$241.03 million, a P/E ratio of -0.88, a P/E/G ratio of 0.42 and a beta of 1.13. The company has a quick ratio of 2.62, a current ratio of 6.95 and a debt-to-equity ratio of 1.13.
Insider Transactions at Organigram
In other news, Senior Officer Paolo De Luca sold 12,014 shares of the company’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of C$2.52, for a total value of C$30,275.28. Company insiders own 31.32% of the company’s stock.
Organigram Company Profile
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Further Reading
- Five stocks we like better than Organigram
- Upcoming IPO Stock Lockup Period, Explained
- XPO Stock Gains Momentum as U.S. Trade Outlook Evolves
- Technology Stocks Explained: Here’s What to Know About Tech
- CarMax Gets in Gear: Is Now the Time to Buy?
- About the Markup Calculator
- Qubit Combat: 2 Stocks Battle for Quantum Supremacy
Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.